Jonathan Kimmelman is an Associate Professor at the Biomedical Ethics Unit / Social Studies of Medicine. He has cross appointments in Experimental Medicine, Epidemiology, Biostatistics and Occupational Health and Human Genetics. Dr. Kimmelman holds a PhD in Molecular Biophysics and Biochemistry from Yale University. Thereafter, he joined McGill in 2005. His research revolves around the ethical, social and policy dimensions of translational research. He received the Institute of Genetics Maud Menten New Investigator Prize, a CIHR New Investigator Award (2008) and a Friedrich Bessel-Humboldt Award (2014). Dr. Kimmelman chaired the ethics committee of the American Society of Gene and Cell Therapy (2008-2010) and currently chairs the ethics committee of the International Society of Stem Cell Research.
Dr. Kimmelman's research centers on the ethical, social and policy challenges in testing novel medical technologies in human beings ("translational clinical research"). Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. Dr. Kimmelman directs the Group Studies of Translation, Ethics and Medicine (STREAM) - translationalethics.com.